1. Home
  2. SCNI vs MEHA Comparison

SCNI vs MEHA Comparison

Compare SCNI & MEHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.32

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

MEHA

Functional Brands Inc.

N/A

Current Price

$0.02

Market Cap

1.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCNI
MEHA
Founded
2003
2020
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.9M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SCNI
MEHA
Price
$0.32
$0.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
326.7K
40.3M
Earning Date
05-11-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.02
52 Week High
$3.47
$0.74

Technical Indicators

Market Signals
Indicator
SCNI
MEHA
Relative Strength Index (RSI) 34.37 28.47
Support Level N/A N/A
Resistance Level $0.94 $0.22
Average True Range (ATR) 0.05 0.01
MACD -0.00 -0.00
Stochastic Oscillator 10.71 2.34

Price Performance

Historical Comparison
SCNI
MEHA

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

About MEHA Functional Brands Inc.

Functional Brands Inc operates in the nutraceutical supplement industry. It is a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, brain and memory, sleep, prenatal and urinary. It is focus on end-consumers through different channels that include pharmacies, wholesalers, international distributors and direct-to-consumers sales. The Company has two reportable segments: 1) Kirkman, which sells a range of nutraceuticals, supplements and related products direct to consumers; 2) HT Naturals, which sells a range of hemp products. Key revenue is generated from Kirkman.

Share on Social Networks: